cancer Flashcards
Skin cancer w worst prognosis
Melanoma
2 types of skin cancer
- Non melanoma (Basal Cell Cancer, SCC)
- Melanoma
Questions asked to patients we suspect have skin cancer
- HISTORY
- Duration
- Change
- Symptoms
- Risk factor assessment
- PMHx, DHx, allergies - EXAMINATION
- Site, size, flat/raised, borders, surface features
- Pigmented - ABCDE
ABCDE - skin
A- Asymmetry
B- irregular Border
C- Colour variation
D- Diameter >6mm
E- Evolution/Elavation
What time of sun exposure is common in patients with BCC/Melanoma
Intense intermittent sun exposure
What time of sun exposure is common in patients with SCC and their precursors
Chronic cumulative (eg. live abroad, work outside)
BASAL CELL CARCINOMA
- Originate from?
- Hx
- Prognosis
- Basal keratinocytes
- Slowly growing, asymptomatic
- Good as don’t metastasise + are locally invasive
BCC Clinical features
- Rolled, pearly, shiny edge
- central ulceration
- telangiectasia
BCC
- 3 subtypes + treatment
- Nodular: Routine excision (3-4mm round it)
- Infiltrative: Mohs surgery/ Wide excision
- Superficial:
- Freeze (liquid nitrogen),
- Creams (i.e: efudex- cytotoxic cream, imiquimod cream)
- Photodynamic therapy
Diagnostic tool used to look at skin cancer lesions
Dermatascope
what type of bcc
Inflitrative
- Wide margin
what type of bcc
Nodular
- Golf ball
- Well defined
what type of bcc
superficial
- flat
SCC
- Originate from
- Hx
- Prognosis
- Supra-basal keratinocytes
- Fast growing (changes over 2-3 months), tender
- Meh, could metastasise - most do not
Most common cancer in immunosuppressed population
SCC
Clinical features of SCC
- Depends on how well-differentiated cells are
- Scaly lumps/ ulcerated lumps
Precursors to SCC + their definitions
- Actinic keratosis (solar keratosis): partial thickness of keratinocyte dysplasia of epidermis
- Bowens disease: full thickness keratinocyte dysplasia of epidermis
Prognosis/Treatment for actinic keratosis and bowens disease
- Treated non-surgically (eg. liquid nitrogen, effudix + education)
- Non life-threatening (as superficial)
actinic keratosis presentation
- scale
- common on sun exposed areas
Bowens disease presentation
- red
What % of:
- Actinic
- Bowens disease
progress into scc
- around1%
- around 5%
risk factors for ssc round mouth
- smoking
- sun exposure
Melanoma
- Arrises from
- Hx
- Prognosis
- Melanocytes
- Changing pigmented lesion, itchy/bleeding
- Poor, all invasive melanomas can metastasise
Melanoma risk factors
- Multiple atypical moles
Multiple atypical moles worrying sign
‘Ugly duckling sign’ - one mole different to the rest (probably a melanoma)
Major + Minor criteria for analysing moles
MAJOR
Change in: shape, size, colour
MINOR
Diameter >6mm, bleeding, sensory change, inflammation
Most common type of melanoma
Superficial spreading melanoma
Walk me thru growth of melanoma
- Horizontal growth - confined to epidermis (no metastatic potential) - normally flat
- Vertical growth (break thru basement membrane + can metastasise) - nb look for lumpy melanoma
Types of melanoma
- Superficial spreading melanoma
- Nodular melanoma
- Lentigo maligna (melanoma)
- Acral lentiginous melanoma
NB- All can be amelanotic melanoma (no pigment)
what type of melanoma is this
Prognosis of nodular melanoma + why
- poor as they grow vertically straight away
Lentigo maligna
- horizontal growth phase lasts years
- Name changes to lentigo malgina once vertical phase is commenced
What type of melanoma is this
What type of melanoma is this
What type of melanoma is this
Where is acral MM commonly seen
palms
soles
nails
Risk factors for acral MM
genetic mutation
What type of melanoma is this
What’s Breslow thickness used for
to measure deepest tumour cell from granular layer of epidermis
- related to tumour prognosis (deeper tumour = poorer prognosis)
Breslow thickness >3.00mm survival
60% 5 year survival
Breslow thickness <0.76 survival
90% 5y survival
Breslow thickness confined to epidermis survival
100% 5y survival
Malignant melanoma treatment
- Surgical excision +/- sentinel node biopsy ( done if Breslow thickness > 0.8)
- Advanced MM (difficult to treat):
- Targeted therapies
- Immunotherapy (to get immune system to attack cancer more)